Evidence map›Paper›PMID 26659577›Full record

ArticleActa neuropathologica2016

Neuronal ceroid lipofuscinosis with DNAJC5/CSPα mutation has PPT1 pathology and exhibit aberrant protein palmitoylation.

Michael X Henderson, Gregory S Wirak, Yong-Quan Zhang, Feng Dai, Stephen D Ginsberg, Natalia Dolzhanskaya, John F Staropoli, Peter C G Nijssen, TuKiet T Lam, Amy F Roth and 4 more

Open access · greenAbstract read
In one paragraph

Article in Acta neuropathologica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Palmitoylation in cardiovascular diseases: Molecular mechanism and therapeutic potential.International journal of cardiology. Heart & vasculature · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Altered Protein Palmitoylation as Disease Mechanism in Neurodegenerative Disorders.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Review
  11. Article
  12. Decoding transcriptomic signatures of cysteine string protein alpha-mediated synapse maintenance.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 2 countries.

Michael X HendersonProgram in Cellular Neuroscience, Neurodegeneration and Repair, Yale University, New Haven, CT, USA.
Gregory S WirakProgram in Cellular Neuroscience, Neurodegeneration and Repair, Yale University, New Haven, CT, USA.
Yong-Quan ZhangProgram in Cellular Neuroscience, Neurodegeneration and Repair, Yale University, New Haven, CT, USA.
Feng DaiYale Center for Analytical Services, New Haven, CT, USA.
Stephen D GinsbergNathan Kline Institute, Orangeburg, NY, USA.
Natalia DolzhanskayaDepartment of Human Genetics, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA.
John F StaropoliDepartment of Neurology, Center for Human Genetics Research, Massachusetts General Hospital, Boston, MA, USA.
Peter C G NijssenDepartment of Neurology, St. Elisabeth Hospital, 5022 GC, Tilburg, Netherlands.
TuKiet T LamDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA.
Amy F RothDepartment of Pharmacology, Wayne State University, Detroit, MI, USA.
Nicholas G DavisDepartment of Pharmacology, Wayne State University, Detroit, MI, USA.
Glyn DawsonDepartment of Pediatrics, University of Chicago, Chicago, IL, USA.
Milen VelinovDepartment of Pediatrics, Albert Einstein College of Medicine, New York, NY, USA.
Sreeganga S ChandraProgram in Cellular Neuroscience, Neurodegeneration and Repair, Yale University, New Haven, CT, USA. sreeganga.chandra@yale.edu.
Yale University · USNew York State Office for People With Developmental Disabilities · USWayne State University · USAnalytical Services · USBiogen (United States) · USElisabeth-TweeSteden Ziekenhuis · NLNathan Kline Institute for Psychiatric Research · USUniversity of Chicago · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
TAU, AB, SYNUCLEIN AND NITRATIVE/OXIDATIVE DAMAGE IN MCIP01AG014449 · NIA · UNIVERSITY OF PITTSBURGH · PI IKONOMOVIC, MILOS D · 1997 to 2024
$39.7M
Yale/NIDA Neuroproteomics Research CenterP30DA018343 · NIDA · YALE UNIVERSITY · PI Marina R Picciotto · 2004 to 2026
$37.1M
Cellular and Molecular Medial Temporal Lobe Pathology in Elderly PreMCI subjectsR01AG043375 · NIA · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI GINSBERG, STEPHEN D, MUFSON, ELLIOTT JAY · 2013 to 2017
$3.6M
Roles of the CSPalpha Chaperone Complex in Presynaptic Maintenance and ANCLR01NS083846 · NINDS · YALE UNIVERSITY · PI CHANDRA, SREEGANGA S · 2014 to 2018
$2.2M
The Physiological Functions of SynucleinsR01NS064963 · NINDS · YALE UNIVERSITY · PI CHANDRA, SREEGANGA S · 2010 to 2014
$1.6M
CSP alpha regulation of exo-endocytic cycle enhances synaptic stabilityF31NS078861 · NINDS · YALE UNIVERSITY · PI HENDERSON, MICHAEL · 2012 to 2013
$45k
NCATS NIH HHS UL1 TR001863NCRR NIH HHS UL1 RR024139NIA NIH HHS P01 AG014449NIA NIH HHS R01 AG043375NIDA NIH HHS 5 P30 DA018343-07NIDA NIH HHS P30 DA018343NINDS NIH HHS F31 NS078861NINDS NIH HHS NIH R01NS083846NINDS NIH HHS NS078861-02NINDS NIH HHS R01 NS064963NINDS NIH HHS R01NS064963NINDS NIH HHS R01 NS083846
6 · The paper itself

Abstract

Neuronal ceroid lipofuscinoses (NCL) are a group of inherited neurodegenerative disorders with lysosomal pathology (CLN1-14). Recently, mutations in the DNAJC5/CLN4 gene, which encodes the presynaptic co-chaperone CSPα were shown to cause autosomal-dominant NCL. Although 14 NCL genes have been identified, it is unknown if they act in common disease pathways. Here we show that two disease-associated proteins, CSPα and the depalmitoylating enzyme palmitoyl-protein thioesterase 1 (PPT1/CLN1) are biochemically linked. We find that in DNAJC5/CLN4 patient brains, PPT1 is massively increased and mis-localized. Surprisingly, the specific enzymatic activity of PPT1 is dramatically reduced. Notably, we demonstrate that CSPα is depalmitoylated by PPT1 and hence its substrate. To determine the consequences of PPT1 accumulation, we compared the palmitomes from control and DNAJC5/CLN4 patient brains by quantitative proteomics. We discovered global changes in protein palmitoylation, mainly involving lysosomal and synaptic proteins. Our findings establish a functional link between two forms of NCL and serve as a springboard for investigations of NCL disease pathways.

Indexed as

AnimalsBrainCells, CulturedCerebral CortexFemaleHSP40 Heat-Shock ProteinsHumansLipoylationMaleMembrane ProteinsMiceMice, KnockoutModels, BiologicalMutationNeuronal Ceroid-LipofuscinosesNeuronscysteine string proteinHSP40 Heat-Shock ProteinsMembrane Proteinspalmitoyl-protein thioesteraseThiolester HydrolasesCysteine-string protein alpha (CSPα)NeurodegenerationNeuronal ceroid lipofuscinosis (NCL)PalmitoylationPalmitoyl-protein thioesterase 1 (PPT1)

Identifiers

PMID26659577
PMCPMC4791186
OpenAlexW2293783413

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.